GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 526 - 550 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgG Patient 3 -180 mild
G41200QS
38
IgG Patient 3 11 mild
G32611KT
38
IgG Patient 3 11 mild
G82348BZ
38
IgG Patient 3 4 mild
G07483YN
38
IgG Patient 3 4 mild
G08520NM
38
IgG Patient 3 4 mild
G73271MD
38
IgG Patient 4 12 mild
G10789DJ
38
IgG Patient 1 10 moderate
G91537AT
39
IgG Patient 1 10 moderate
G98240FC
39
IgG Patient 1 22 moderate
G29011JC
39
IgG Patient 1 22 moderate
G35446HX
39
IgG Patient 1 22 moderate
G42346AP
39
IgG Patient 1 22 moderate
G61399NC
39
IgM Patient 1 10 moderate
G58547FH
39
IgM Patient 1 10 moderate
G99603GB
39
IgG Patient 1 6 moderate
G35446HX
39
IgM Patient 1 6 moderate
G15209MJ
39
IgM Patient 1 6 moderate
G32699RJ
39
IgM Patient 1 6 moderate
G72424VO
39
IgM Patient 1 6 moderate
G78255UI
39
IgM Patient 1 6 moderate
G98068PA
39
IgG Patient 2 15 mild
G25473LQ
39
IgG Patient 2 15 mild
G63074CQ
39
IgG Patient 2 24 mild
G19868AX
39
IgM Patient 2 15 mild
G96881BQ
39

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024